Gene · 5880
Papers3,143
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,143
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Mitochondria in the Regulation of Effector Functions of Granulocytes. | Cells | 2023 | 37759432 | PubTator, text mining | PubMed |
| Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension. | Front Immunol | 2023 | 37753070 | PubTator, text mining | PubMed |
| Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells. | Nat Biomed Eng | 2023 | 37749310 | PubTator, text mining | PubMed |
| Local negative feedback of Rac activity at the leading edge underlies a pilot pseudopod-like program for amoeboid cell guidance. | PLoS Biol | 2023 | 37747905 | PubTator, text mining | PubMed |
| Role of neutrophil extracellular trap and immune infiltration in atherosclerotic plaque instability: Novel insight from bioinformatics analysis and machine learning. | Medicine (Baltimore) | 2023 | 37747003 | PubTator, text mining | PubMed |
| M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction. | Sci Rep | 2023 | 37735234 | PubTator, text mining | PubMed |
| Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasion. | Front Genet | 2023 | 37719704 | PubTator, text mining | PubMed |
| Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma. | Cancer Sci | 2023 | 37715346 | PubTator, text mining | PubMed |
| Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis. | Am J Physiol Cell Physiol | 2023 | 37694283 | PubTator, text mining | PubMed |
| The link between psoriasis and other diseases based on epidemiological and genetic analyses. | Postepy Dermatol Alergol | 2023 | 37692276 | PubTator, text mining | PubMed |
| Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS). | Int J Mol Sci | 2023 | 37686271 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. | Commun Biol | 2023 | 37684337 | PubTator, text mining | PubMed |
| Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile. | Microbiol Spectr | 2023 | 37668373 | PubTator, text mining | PubMed |
| Metabolic signature and proteasome activity controls synovial migration of CDC42hiCD14+ cells in rheumatoid arthritis. | Front Immunol | 2023 | 37662900 | PubTator, text mining | PubMed |
| Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study. | Neurology | 2023 | 37657941 | PubTator, text mining | PubMed |
| Benchmarking of force fields to characterize the intrinsically disordered R2-FUS-LC region. | Sci Rep | 2023 | 37648703 | PubTator, text mining | PubMed |
| The Janus face of proliferating plasmablasts in dengue and COVID-19 infections. | Front Immunol | 2023 | 37638019 | PubTator, text mining | PubMed |
| Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer. | Front Oncol | 2023 | 37637068 | PubTator, text mining | PubMed |
| Disease-microenvironment modulation by bare- or engineered-exosome for rheumatoid arthritis treatment. | Biomater Res | 2023 | 37635253 | PubTator, text mining | PubMed |
| The Activation of the LIMK/Cofilin Signaling Pathway via Extracellular Matrix-Integrin Interactions Is Critical for the Generation of Mature and Vascularized Cardiac Organoids. | Cells | 2023 | 37626839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5880/papers?page=10